Skip to content

Early Warning Scores in Pregnant Woman

Effectiveness of Early Warning Scores: Preoperative Period in Pregnant Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06488690
Enrollment
304
Registered
2024-07-05
Start date
2022-04-01
Completion date
2024-02-01
Last updated
2024-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Complications

Keywords

Early Warning Scores, MEOWS, MEWC, MEWT, Pregnant Women, Maternal Morbidity

Brief summary

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

Detailed description

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section. This prospective study included 304 patients undergoing cesarean section at Suleyman Demirel University between April 2022 and April 2023. Physiological parameters were assessed in all 304 pregnant women before the operation. Maternal early warning scores, including modified early obstetric warning score (MEOWS), maternal early warning score (MEWC), and maternal early warning triggers (MEWT), were calculated for each patient. Patients triggering the system were classified as Group 1 (risky patients), while those not triggering the system were classified as Group 2 (risk-free patients).

Interventions

OTHERAll patients who were pregnant and underwent cesarean section

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

Sponsors

Suleyman Demirel University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Pregnant woman

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* All patients who are pregnant and undergo cesarean section

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
MEOWS, MEWC and MEWT scoresOne yearThe presence of a trigger for MEOWS in all systems, defined as either a single severely abnormal parameter (falling in the red zone) or two slightly abnormal parameters (falling in the yellow zone), was categorized as the risky group. Absence or mildness of the trigger was considered as the risk-free group.
MEWC scoreOne yearIn the case of MEWC, the presence of only one abnormal parameter designated the risk group, while the absence of a trigger indicated the risk-free group.
MEWT scoreOne yearFor MEWT, the presence of a trigger defined as either a single severely abnormal parameter (falling in the red zone) or two mildly abnormal parameters (falling in the yellow zone) was categorized as the risky group, with the absence or mildness of the trigger considered as the risk-free group.

Secondary

MeasureTime frameDescription
APGAR scoreOne yearAPGAR scores at 1st and 5th minutes were calculated for postnatal babies.
Aldrete scoreOne yearThe Modified Aldrete Recovery Score System was computed for mothers to assess postoperative recovery.
Glasgow Coma ScaleOne yearThe Glasgow Coma Scale (GCS) was used to evaluate the consciousness of pregnant women.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026